Viewing StudyNCT00101192



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00101192
Status: COMPLETED
Last Update Posted: 2014-03-17
First Post: 2005-01-07

Brief Title: Cetuximab and Cisplatin in Treating Patients With Advanced Persistent or Recurrent Cervical Cancer
Sponsor: Gynecologic Oncology Group
Organization: GOG Foundation

Organization Data

Organization: GOG Foundation
Class: NETWORK
Study ID: GOG-0076DD
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Gynecologic Oncology Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Bristol-Myers Squibb INDUSTRY
National Cancer Institute NCI NIH